More on the safety of autologous stem cell re-implants for knees

stem cell safety complications isscr close look closer look

stem cell safety complications

Great study this am out of Japan, where they report on the complications from the longest running surveillance program for a mesenchymal stem cell re-implants in the knee.  They looked at 45 knees in 41 patients for an average of between 5-137 months (11 years plus).  They observed no tumors or other issues with the re-implants.  This is consistent with our own published safety data on 227 patients as well as our recent analysis of 339 patients with about 60 sites tracked by 3.0T MRI (the latter not yet submitted for publication).  The data continues to support the excellent safety record of MSC’s used for orthopedic purposes.

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP